Covid-19 brought unprecedented global turmoil leading to millions of infections and deaths. Public
procurement has been a core element of government responses to the pandemic.

Extant evidence has, however, shown that public procurement is generally prone to corruption, notably
pharmaceutical and health-sector related procurements which historically have been associated with
higher corruption risks.

Find out more and hear our recommendations in our latest publication:

Openness and transparency in Covid-19 financing, vaccine procurement and deployment a comparative analysis from selected African countries: a compartive analysis